TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-Κb. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells.

TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-κB. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells.

322455-70-9

C84H140N14O18S

1666.16

FSL 1;FSL-1

H2O:2 mg/mL
Powder: -20°C for 3 years
In solvent: -80°C for 2 years